What is Hangzhou Minsheng Healthcare Co., Ltd.'s (301507.SZ) StockRank?

MoatMap's StockRank for Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) is 44/100, with a Hold signal. This is a composite score combining Quality (68), Value (29), and Momentum (41) factor ranks across MoatMap's 20,000+ stock universe.

Does Hangzhou Minsheng Healthcare Co., Ltd. have an economic moat?

Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Hangzhou Minsheng Healthcare Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) is Hold, based on a StockRank of 44/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Hangzhou Minsheng Healthcare Co., Ltd. in?

Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

301507.SZ

HOLD

Hangzhou Minsheng Healthcare Co., Ltd. · Healthcare · China · $633M · Avg Vol: $6M/d

StockRank

Get insider-trade alerts

P/E (TTM)

36.8x

ROE

7.0%

D/E

0.0x

Dividend %

1.3%

COMPANY DESCRIPTION

Hangzhou Minsheng Healthcare Co., Ltd. develops, produces, and markets over-the-counter (OTC) medicines and dietary supplements, with its multi-vitamin brand '21 Jin Weita' holding a leading market share in China. The company benefits from deep brand equity and an extensive retail pharmacy distribution network across the country. Its focus on preventative healthcare and consumer health products provides resilient cash flows and steady growth.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM
Revenue	80.6M	85.7M	94.4M	115.1M	12.6%	121.9M
EPS	0.04	0.04	0.04	0.05	3.2%	0.05
Shares	267.4M	356.6M	356.6M	356.6M	+33.3%	356.6M
Debt	0.4M	0.3M	0.2M	0.4M	-3.0%	0.5M
Equity	87.5M	217.0M	225.5M	235.4M	39.1%	—
Op CF	14.0M	15.9M	16.0M	26.1M	23.0%	25.3M
Inv CF	-10.2M	-75.7M	-41.2M	-6.9M	—	—
Fin CF	-0.9M	117.0M	-5.6M	-10.7M	—	—

Loading 1Y...

PRICE (1Y)-6.1%

SMA 50SMA 200

$1.78

RSI (14)

45.7

52W High

$2.80

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

7.8%66.4

ROE

7.0%62.6

GP/Assets

21.3%49.5

Op. Margin

24.3%87.8

FCF/Assets

2.1%54.3

Piotroski

676.2

Int. Cover

50.0x88.5

D/E Ratio

0.00x96.0

Current Ratio

3.83x63.5

Value

P/E (TTM)

36.8x30.9

EV/EBITDA

28.3x20.7

P/FCF

99.5x14.1

P/B

2.6x49.4

P/S

5.2x41.2

Div Yield

1.3%32.5

Momentum

52W High %

64%40.9

RS 6M

-24%40.3

SMA 50/200

0.90x40.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

0%40.0

FUNDAMENTALS

Market Cap

$633M

P/E (Forward)

—

Gross Margin

51.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 301507.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
301507.SZ	Hangzhou Minsheng Healthcare Co., Ltd.(you)	$633M	44	HOLD
600771.SS	GuangYuYuan Chinese Herbal Medicine Co., Ltd.	$916M	48	HOLD
300006.SZ	Chongqing Lummy Pharmaceutical Co., Ltd.	$698M	33	SELL
002019.SZ	Yifan Pharmaceutical Co., Ltd.	$1.7B	38	HOLD
301096.SZ	Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.	$961M	21	SELL
688710.SS	Shanghai InnoStar Bio-tech Co., Ltd.	$1.3B	62	HOLD
300357.SZ	Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.	$1.6B	61	HOLD
600666.SS	Aurora Optoelectronics Co.,Ltd.	$1.7B	25	SELL
1643.HK	Modern Chinese Medicine Group Co., Ltd.	$127M	37	HOLD
600713.SS	Nanjing Pharmaceutical Group Company Limited	$977M	77	BUY

Peer medians: ROE 4.7% · P/E 28.4x · Gross margin 52.5%

Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) — Stock Score Summary

Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) has a MoatMap StockRank of 44/100 based on Quality (68/100), Value (29/100), and Momentum (41/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$1.78
Market Cap	$633M
P/E (TTM)	36.76
Price/Book	2.61
Return on Equity	7.0%
Return on Invested Capital	7.8%
Debt/Equity	0.19
Gross Margin	51.8%
Operating Margin	24.3%
Revenue Growth	17.0%
Dividend Yield	1.3%
Free Cash Flow	$6M

Hangzhou Minsheng Healthcare Co., Ltd. operates in the Drug Manufacturers - General industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Hangzhou Minsheng Healthcare Co., Ltd.’s (301507.SZ) StockRank?: MoatMap’s StockRank for Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) is 44/100, with a Hold signal. It is a composite of Quality (68), Value (29), and Momentum (41) factor ranks across MoatMap’s 20,000+ stock universe.
Does Hangzhou Minsheng Healthcare Co., Ltd. have an economic moat?: Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hangzhou Minsheng Healthcare Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) is Hold, based on a StockRank of 44/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hangzhou Minsheng Healthcare Co., Ltd. in?: Hangzhou Minsheng Healthcare Co., Ltd. (301507.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (China).